A phase ib study of alpelisib or buparlisib combined with tamoxifen plus goserelin in premenopausal women with HR-positive HER2-negative advanced breast cancer
Journal
Clinical Cancer Research
Journal Volume
27
Journal Issue
2
Pages
408-417
Date Issued
2021
Author(s)
Lee K.S.
Chao T.-Y.
Tseng L.-M.
Chitapanarux I.
Chen S.-C.
Liu C.-T.
Sohn J.
Kim J.H.
Chang Y.-C.
Yang Y.
Shotelersuk K.
Jung K.H.
Valenti R.
Slader C.
Gao M.
Park Y.H.
SDGs
Publisher
American Association for Cancer Research Inc.
Type
journal article